Categories: Healthcare

Medicated Bath Additive Market Market Segmentation, Scope And Drivers Report To 2033 |ohnson & Johnson, LVMH Moët Hennessy Louis Vuitton S.E., Unilever plc, L’Oréal S.A.

Overview and Scope
A medicated bath additive is a product designed to be added to bathwater to provide therapeutic benefits or address specific skin or health issues. The primary purpose of medicated bath additives is to address specific skin conditions, promote relaxation, relieve muscle aches, or offer other therapeutic effects.

Sizing and Forecast
The medicated bath additive market size has grown strongly in recent years. It will grow from 29.21 billion in 2023 to $31.45 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to need for improving skin tone, increasing demand for affordable bathing additive products, consumption of premium bath bombs and bubbles, increasing demand for powder type bath additives, growing demand for adult type bath additives.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/medicated-bath-additive-global-market-report

The medicated bath additive market covered in this report is segmented –

1) By Product: Bath Bombs, Bath Soaps, Shower gel, Shampoo, Conditioner, Accessories
2) By Form: Solid, Gels And Jellies, Liquid, Other Forms
3) By Gender: Male, Female
4) By Distribution Channel: Retail Pharmacies, Supermarket Or Hypermarket, Online Sales, General Stores, Cosmetic Stores

North America was the largest region in the medicated bath additive market in 2023. The regions covered in the medicated bath additive market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=13878&type=smp

Major Driver Impacting Market Growth
The rising prevalence of skin conditions is expected to propel the growth of the medicated bath additive market going forward. Skin conditions refer to any abnormality, disorder, or disease that affects the skin, which is the largest organ of the body. The prevalence of skin conditions prompts the utilization of medicated bath additives, as they offer targeted therapeutic benefits by delivering active ingredients directly to the skin, addressing symptoms, and promoting overall skin health. For instance, in August 2021, according to the Centers for Disease Control (CDC), a US-based federal government agency for the prevention and control of diseases, more than 7.5 million people in the USA and over 125 million people globally suffered from psoriasis, one of the most prevalent chronic cutaneous dermatitis. Therefore, the rising prevalence of skin conditions is driving the growth of the medicated bath additive market.

Key Industry Players
Major companies operating in the medicated bath additive market report are Johnson & Johnson, LVMH Moët Hennessy Louis Vuitton S.E., Unilever plc, L’Oreal S.A., Reckitt Benckiser Group plc, Estée Lauder Companies Inc., Galderma S.A., Revlon Inc., Croda International plc, Lupin Limited, L’Occitane International S.A., Piramal Pharma Limited, Kneipp GmbH, Shanghai Jahwa United Co. Ltd., Lush Cosmetics Ltd., Almirall S.A., Himalaya Wellness Company, Weleda AG, Fine Organic Industries Limited, Tom’s of Maine Inc., Herbivore Botanicals LLC, Westlab ltd., Acure Organics, Borghese Inc., Nardo’s Naturals, Soothing Touch, The Mother Soap Co., Buff City Soap, Bath & Body Works, The Body Shop

The medicated bath additive market report table of contents includes:

1. Executive Summary

2. Medicated Bath Additive Characteristics

3. Medicated Bath Additive Trends And Strategies

4. Medicated Bath Additive – Macro Economic Scenario

5. Global Medicated Bath Additive Size and Growth

…..

32. Global Medicated Bath Additive Competitive Benchmarking

33. Global Medicated Bath Additive Competitive Dashboard

34. Key Mergers And Acquisitions In The Medicated Bath Additive

35. Medicated Bath Additive Future Outlook and Potential Analysis

36. Appendix